IV NAD+ infusions are typically administered over 2-4 hours due to potential flushing and nausea with rapid infusion
Multiple nodules in both lungs, obscured by consolidation
10.1096/fasebj.13.2.297 16 BuzhdyganT
When compared with placebo or other therapies, GLP-1 agonists were associated with an increased risk of biliary disease [23]: Overall biliary disease: RR 1.37(95% CI 1.231.52) Cholelithiasis: RR 1.27 (95% CI 1.101.47) Cholecystitis: RR 1.36 (95% CI 1.141.62) Mechanisms: Reduced gallbladder motility Rapid weight loss increased cholesterol saturation and gallstone formation
The studies featured follow-up periods ranging from 6 to 12 months and measured outcomes including on-treatment weight loss, HbA1c changes, and heterogeneous cardiovascular events (e.g., all-cause mortality, myocardial infarction, and stroke)
The information presented on this page is provided for scientific and educational purposes only